On June 11–12, 2025, another working meeting took place in Istanbul between representatives of JSC “National Holding QazBioPharm” and their French partners from Boehringer Ingelheim Animal Health France. The meeting was held within the framework of the cooperation agreement signed on January 16, 2024.

The central theme of the meeting was the discussion of current and upcoming areas of cooperation regarding the production of a vaccine against foot-and-mouth disease in animals. The parties reviewed ongoing progress, explored prospects for collaboration, and discussed coordination mechanisms for the next stages of the project.

The meeting was conducted in a spirit of constructive dialogue. As a result, both parties reaffirmed their mutual interest in strengthening the strategic partnership and reached a number of preliminary agreements. Future cooperation will focus on production, scientific research, and personnel training in accordance with international standards.